Biotech Company GangaGen raises $1.8mn

Total
0
Shares

Bangalore (and US) based Biotech research company, GangaGen has raised $1.8mn from ATEL ventures.

The funding will be used to develop treatments for antibiotic-resistant bacterial infections like MRSA, a skin infection that plagues hospitals, and pneumonia (via)

Recommended Read: Green Tech Investments in India | The Great Indian Energy Innovation!

Leave a Reply

Sign Up for Our Newsletters

Get notified of latest industry interviews and insights!

You May Also Like

Devs Can Target Android & Fire Users With Amazon’s New Ad Platform

The company claims setting up campaigns takes as little as 90 seconds. The minimum amount advertisers can spend is $100 and devs get charged only when users click on the ads. Devs can also select what type of users they want to acquire based on their interests, or even let Amazon do the selecting for them. The “Enable Google Play Support” option that allows users who don’t have the Amazon Appstore installed to download the app from the Play Store.
View Post